The role and therapeutic potential of monocytic cells in Alzheimer's disease
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a dementing neurodegenerative disorder without a cure. The abnormal parenchymal accumulation of β‐amyloid (Aβ) is associated with inflammatory reactions involving microglia and astrocytes. Increased levels of Aβ and Aβ deposition in the brain are thought to cause neuronal dysfunction and underlie dementia. Microglia, the brain resident cells of monocytic origin, have a potential ability to phagocytose Aβ but they also react to Aβ by increased production of proinflammatory toxic agents. Microglia originate from hemangioblastic mesoderm during early embryonic stages and from bone marrow (BM)‐derived monocytic cells that home the brain throughout the neonatal stage of development. Recent studies indicate that BM or blood‐derived monocytes are recruited to the diseased AD brain, associate with the Aβ depositions, and are more efficient phagocytes of Aβ compared with resident microglia. The clearance of Aβ deposition by these cells has been recently under intensive investigation and can occur through several different mechanisms. Importantly, peripheral monocytic cells of patients with AD appear to be deficient in clearing Aβ. This review will summarize the findings on the role of blood‐derived cells in AD and discuss their therapeutic potential for treating patients suffering from this devastating disease. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 2×
“Today the role of microglia is seen more complex (Hanisch and Kettenmann, 2007) having several, fairly specific modes of increased functions rather than simplistic on–off, activated and resting, phenotypes.”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“According to the amyloid cascade hypothesis, originally proposed by Hardy and Allsop (1991), toxic Ab peptides are thought to underlie the cognitive impairment of the patients.”
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 2×
“encoding either amyloid precursor protein (APP) or presenilin 1/2 may increase the production of Ab (Hardy, 1997).”
BackgroundMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 2×
“Leukocyte expression of CD36 has been reported to be low in patients with AD or mild cognitive impairment as well as in old AD mice (Hickman et al., 2008).”
BackgroundResultActivation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · cited 1×
“…hallmark of AD (Akiyama et al., 2000; Haga et al., 1989; Itagaki et al., 1989; Kim and de Vellis, 2005; Koistinaho and Koistinaho, 2005; Meda et al., 1995; Rogers and Lue, 2001; Rogers et al., 2002; Sheng et al., 1997; Smits et al., 2002; Strohmeyer et al., 2005; Walker and Lue, 2005;…”
BackgroundDeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298 · cited 1×
“…has been shown to lead to a reduction in the brain Ab burden especially in immunization studies, in which peripheral administration of antibodies against Ab peptide sequestered peripheral pool of Ab and subsequently caused a reduction in the parenchymal levels of Ab (DeMattos et al., 2001, 2002).”
BackgroundTsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152 · cited 1×
“…remotely, as CCR2 and MCP3, as well as CCL2 to lesser extent, play a critical role in monocyte mobilization from the BM and monocyte engraftment to inflammatory sites, including the brain (Charo and Peters, 2003; Huang et al., 2005; Martin et al., 2008; Tsou et al., 2007; Yamamoto et al., 2005).”
BackgroundSubpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
Sunderkötter, C., Nikolic, T., Dillon, M. J., van Rooijen, N., Stehling, M., Drevets, D. A., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4410 · Cited by 1,124
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 5×
“These findings suggests that BM/blood-derived monocytic cells could be modified for therapeutic purposes in a way that their rather limited engraftment into the brain (Mildner et al., 2007) would not be an issue at all.”
BackgroundResultInfluentialTikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634 · cited 1×
“Rather than directly suppressing microglial activation, nonsteroidal anti-inflammatory agents exhibit their beneficial effect in AD by directly decreasing g-secretase activity (Eriksen et al., 2003; Weggen et al., 2003).”
BackgroundApolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · cited 3×
“Adult astrocytes also clear Ab efficiently both ex vivo (Koistinaho et al., 2004) and in vivo when administered intracranially in the AD mouse brain (Pihlaja et al., 2008) but whether astrocytes clear Ab in human AD brain is not clear.”
BackgroundMethodSelf-citationDeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., & Holtzman, D. M. (2002) · Science · doi:10.1126/science.1067568 · Cited by 563
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506 · cited 1×
“Patients with AD may have infectious agents associated with amyloid plaques and neurofibrillary tangles (Balin et al., 1998; Miklossy et al., 2004) and infections have been thought to contribute to the acceleration of inflammation in the AD brain (reviewed in Honjo et al., 2009).”
BackgroundA Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493 · cited 1×
“Moreover, stimulation of microglial cells with TLR2 and TLR4 ligands boosts indirect clearance of Ab in vitro (Tahara et al., 2006).”
BackgroundBlocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422 · cited 3×
“…due to blocking of TGFb signaling specifically in peripheral monocytic cells lead to significant reduction in brain parenchymal Ab in vivo (Town et al., 2008) Another study found that perivascular monocytic cells regulated the accumulation of Ab in cerebral blood vessels (Hawkes and…”
BackgroundInfluentialHawkes, C. A., & McLaurin, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805453106 · Cited by 397
Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604681103 · Cited by 388 · cited 2×
“…evidence that the compromised blood-brain barrier (BBB) in severe brain diseases, such as stroke or brain trauma (Priller et al., 2001), and AD (Butovsky et al., 2006; Fiala et al., 2002; Malm et al., 2005, 2008; Simard et al., 2006; Stalder et al., 2005) allows leakage of blood-derived…”
BackgroundMicroglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00994.x · Cited by 307 · cited 5×
“…the compromised blood-brain barrier (BBB) in severe brain diseases, such as stroke or brain trauma (Priller et al., 2001), and AD (Butovsky et al., 2006; Fiala et al., 2002; Malm et al., 2005, 2008; Simard et al., 2006; Stalder et al., 2005) allows leakage of blood-derived monocytes into the brain.”
BackgroundInfluentialMalm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301
Self-citationRichard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1146-08.2008 · Cited by 298 · cited 1×
“Gene delivery of TLR2-lentivirus into the BM cells can rescue the cognitive decline of TLR2 deficient AD mice (Richard et al., 2008).”
BackgroundISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · cited 2×
“In the brain, CCL2 is expressed at least by microglia and astrocytes (El Khoury et al., 2007; Smits et al., 2002), and is induced by neurodegenerative processes, including AD (Ishizuka et al., 1997).”
BackgroundRogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Kim, W.-K., Alvarez, X., Fisher, J., Bronfin, B., Westmoreland, S., McLaurin, J., & Williams, K. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050215 · Cited by 225
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223 · cited 4×
“Minocycline treatment inhibited the LPSinduced engraftment of BM/blood-derived cells and decreased the number of MHC-II and Iba-1 (a marker for cells of monocytic lineage) positive cells without preventing the LPS-induced Ab clearance or altering the overall number of CD45 and CD68-positive cells in the injection site.”
InfluentialGiri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K.-S., Zlokovic, B., & Kalra, V. K. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.6.c1772 · Cited by 218
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain
D’Andrea, M. R., Cole, G. M., & Ard, M. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.026 · Cited by 215 · cited 1×
“Microglia (reviewed in D’Andrea et al., 2004) and blood-derived monocytic cells (Fiala et al., 2007a) are capable of phagocytosing Ab from the brain parenchyma but whereas this ability to phagocytose has been extensively reported both in vitro and in vivo models on microglia/monocytic cells,…”
BackgroundMiklossy, J., Khalili, K., Gern, L., Ericson, R. L., Darekar, P., Bolle, L., Hurlimann, J., & Paster, B. J. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6608 · Cited by 163
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice
Wegiel, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00181-0 · Cited by 159
Yamamoto, M., Horiba, M., Buescher, J. L., Huang, D., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62364-4 · Cited by 137 · cited 2×
“VC 2010 Wiley-Liss, Inc. 2008 Schenk et al., 1999; Simard et al., 2006; Yamamoto et al., 2005).”
Background
Cited by
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Furthermore, some studies have shown that perivascular macrophages rather than resident microglia are responsible for the physiological degradation of A β , a function that has been previously attributed to microglial cells (El Khoury et al., 2007; Hawkes and McLaurin, 2009; Malm et al., 2010).”
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
Lampron, A., ElAli, A., & Rivest, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.005 · Cited by 284
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262
Metadata
- Authors
- Malm, T., Koistinaho, M., Muona, A., Magga, J., & Koistinaho, J.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2010-02-12
- Volume
- 58
- Issue
- 8
- Pages
- 889-900
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2041069911
- Cited by
- 106
- References
- 39
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.